149 related articles for article (PubMed ID: 37714384)
1. The conceivable role of prolactin hormone in Parkinson disease: The same goal but with different ways.
Al-Kuraishy HM; Jabir MS; Al-Gareeb AI; Albuhadily AK
Ageing Res Rev; 2023 Nov; 91():102075. PubMed ID: 37714384
[TBL] [Abstract][Full Text] [Related]
2. A story of the potential effect of non-steroidal anti-inflammatory drugs (NSAIDs) in Parkinson's disease: beneficial or detrimental effects.
Alrouji M; Al-Kuraishy HM; Al-Gareeb AI; Saad HM; Batiha GE
Inflammopharmacology; 2023 Apr; 31(2):673-688. PubMed ID: 36961665
[TBL] [Abstract][Full Text] [Related]
3. Glial cells as mediators of protective actions of prolactin (PRL) in the CNS.
Anagnostou I; Reyes-Mendoza J; Morales T
Gen Comp Endocrinol; 2018 Sep; 265():106-110. PubMed ID: 29378204
[TBL] [Abstract][Full Text] [Related]
4. Prolactin-induced neuroprotection against excitotoxicity is mediated via PI3K/AKT and GSK3β/NF-κB in primary cultures of hippocampal neurons.
Molina-Salinas G; Rodríguez-Chávez V; Langley E; Cerbon M
Peptides; 2023 Aug; 166():171037. PubMed ID: 37301481
[TBL] [Abstract][Full Text] [Related]
5. Post-treatment with prolactin protects hippocampal CA1 neurons of the ovariectomized female rat against kainic acid-induced neurodegeneration.
Reyes-Mendoza J; Morales T
Neuroscience; 2016 Jul; 328():58-68. PubMed ID: 27126559
[TBL] [Abstract][Full Text] [Related]
6. The Mechanistic Role of Thymoquinone in Parkinson's Disease: Focus on Neuroprotection in Pre-Clinical Studies.
Uddin MN; Hoq MI; Jahan I; Siddiqui SA; Clinton CD; Ibrahim M; Islam MS; Jakaria M
Curr Mol Pharmacol; 2021; 14(6):1083-1092. PubMed ID: 33402092
[TBL] [Abstract][Full Text] [Related]
7. Therapeutic potentials of plant iridoids in Alzheimer's and Parkinson's diseases: A review.
Dinda B; Dinda M; Kulsi G; Chakraborty A; Dinda S
Eur J Med Chem; 2019 May; 169():185-199. PubMed ID: 30877973
[TBL] [Abstract][Full Text] [Related]
8. Prolactin and Its Altered Action in Alzheimer's Disease and Parkinson's Disease.
Duc Nguyen H; Pal Yu B; Hoang NHM; Jo WH; Young Chung H; Kim MS
Neuroendocrinology; 2022; 112(5):427-445. PubMed ID: 34126620
[TBL] [Abstract][Full Text] [Related]
9. Prolactin mediates neuroprotection against excitotoxicity in primary cell cultures of hippocampal neurons via its receptor.
Vergara-Castañeda E; Grattan DR; Pasantes-Morales H; Pérez-Domínguez M; Cabrera-Reyes EA; Morales T; Cerbón M
Brain Res; 2016 Apr; 1636():193-199. PubMed ID: 26874070
[TBL] [Abstract][Full Text] [Related]
10. Orexin pathway in Parkinson's disease: a review.
Alrouji M; Al-Kuraishy HM; Al-Gareeb AI; Zaafar D; Batiha GE
Mol Biol Rep; 2023 Jul; 50(7):6107-6120. PubMed ID: 37155018
[TBL] [Abstract][Full Text] [Related]
11. Prolactin neuroprotective action against excitotoxic insult in the hippocampus of male mice.
Anagnostou I; Muñoz-Mayorga D; Morales T
Peptides; 2021 Jan; 135():170425. PubMed ID: 33053420
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of the JAK/STAT Pathway Protects Against α-Synuclein-Induced Neuroinflammation and Dopaminergic Neurodegeneration.
Qin H; Buckley JA; Li X; Liu Y; Fox TH; Meares GP; Yu H; Yan Z; Harms AS; Li Y; Standaert DG; Benveniste EN
J Neurosci; 2016 May; 36(18):5144-59. PubMed ID: 27147665
[TBL] [Abstract][Full Text] [Related]
13. Both prolactin (PRL) and a molecular mimic of phosphorylated PRL, S179D-PRL, protect the hippocampus of female rats against excitotoxicity.
Morales T; Lorenson M; Walker AM; Ramos E
Neuroscience; 2014 Jan; 258():211-7. PubMed ID: 24252319
[TBL] [Abstract][Full Text] [Related]
14. Prolactin: Friend or Foe in Central Nervous System Autoimmune Inflammation?
Costanza M; Pedotti R
Int J Mol Sci; 2016 Dec; 17(12):. PubMed ID: 27918427
[TBL] [Abstract][Full Text] [Related]
15. Function of dopamine receptors in Parkinson's disease: prolactin responses.
Laihinen A; Rinne UK
Neurology; 1986 Mar; 36(3):393-5. PubMed ID: 3081830
[TBL] [Abstract][Full Text] [Related]
16. Prolactin prevents mitochondrial dysfunction induced by glutamate excitotoxicity in hippocampal neurons.
Rivero-Segura NA; Coronado-Mares MI; Rincón-Heredia R; Pérez-Torres I; Montiel T; Pavón N; Cabrera-Reyes EA; Massieu L; Cerbón M
Neurosci Lett; 2019 May; 701():58-64. PubMed ID: 30790645
[TBL] [Abstract][Full Text] [Related]
17. Decoding signaling pathways involved in prolactin-induced neuroprotection: A review.
Molina-Salinas G; Rivero-Segura NA; Cabrera-Reyes EA; Rodríguez-Chávez V; Langley E; Cerbon M
Front Neuroendocrinol; 2021 Apr; 61():100913. PubMed ID: 33766566
[TBL] [Abstract][Full Text] [Related]
18. A Pharmacological Appraisal of Neuroprotective and Neurorestorative Flavonoids Against Neurodegenerative Diseases.
Zhao J; Zhu M; Kumar M; Ngo FY; Li Y; Lao L; Rong J
CNS Neurol Disord Drug Targets; 2019; 18(2):103-114. PubMed ID: 30394219
[TBL] [Abstract][Full Text] [Related]
19. Icariin: A Potential Neuroprotective Agent in Alzheimer's Disease and Parkinson's Disease.
Khezri MR; Ghasemnejad-Berenji M
Neurochem Res; 2022 Oct; 47(10):2954-2962. PubMed ID: 35802286
[TBL] [Abstract][Full Text] [Related]
20. Anti-Inflammatory and Neuroprotective Mechanisms of GTS-21, an α7 Nicotinic Acetylcholine Receptor Agonist, in Neuroinflammation and Parkinson's Disease Mouse Models.
Park JE; Leem YH; Park JS; Kim DY; Kang JL; Kim HS
Int J Mol Sci; 2022 Apr; 23(8):. PubMed ID: 35457238
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
